Latest News
Liberty Steel's future in doubt as Greensill Capital teeters
The future of one of Britain’s largest industrial groups is at risk, it emerged on Monday afternoon, as specialist bank Greensill Capital teetered on the brink.
Apollo and Athene to form $29bn conglomerate
Apollo Global Management has agreed to merge with Athene Holding in a deal that will turn the US alternative asset manager into a conglomerate with businesses ranging from private equity to life insurance.
Bavarian Nordic posts positive pre-clinical trial data for Covid-19 vaccine
Shares in Bavarian Nordic surged at the start following the release of positive pre-clinical trial data for its Covid-19 vaccine candidate, ABNCoV2.
Economists revise forecasts for 2021 US GDP growth sharply higher
The high likelihood that Democrats in the US Senate will get their $1. 9trn fiscal stimulus proposal through the US Congress has seen economists revise their forecasts for economic growth in 2021 sharply higher.
Digital 9 to list shares and buy Aqua Comms
Digital 9 Infrastructure, a newly formed investment trust, announced plans to list its shares and then buy Aqua Comms, an owner and operator of subsea transatlantic fibre optic cables, as its first investment.
Sound Energy nets EUR 0.18m from sale of first land stage at Badile
Morocco-focussed upstream gas company Sound Energy announced on Monday that it has received the first sale proceeds from the sale of the Badile land, totalling €0. 18m (£0. 15m) net of fees.
Genel Energy's Sarta-2 well enters production
Genel Energy said on Monday that the Sarta-2 well, in which it has a 30% working interest, has entered production, with gross field production now in excess of 10,000 barrels of oil per day.
Berenberg raises target price on Aggreko
Analysts at Berenberg more than doubled their target price on Aggreko from 410. 0p to 880. 0p on Monday after a buy-out offer from a consortium made up of TDR Capital and I Squared was recommended by the group's board.
Investor morale continues to grow across Eurozone
Investor confidence is continuing to grow in the Eurozone, research published on Monday confirmed, boosted by the worldwide rollout of the Covid-19 vaccine.
DuPont to buy Laird Performance Materials from Advent for $2.3bn
DuPont has agreed to buy Laird Performance Materials from private equity firm Advent International for $2. 3bn in cash.
EU agrees WTO agriculture quotas with US following Brexit
The European Union and the United States have concluded negotiations to implement the EU's agricultural quotas under World Trade Organization rules following the UK’s exit from the bloc.
Panasonic to buy Blue Yonder for $6.5bn
Panasonic Corp is set to buy US software firm Blue Yonder for $6. 45bn in its biggest acquisition deal since 2011, Nikkei reported on Monday.
Fintech unicorn WeLab raises $75m in funding round led by Allianz
Hong Kong’s fintech unicorn company WebLab has raised $75m in its latest funding round which was led by Allianz X.
US pre-open: Futures in the red as heightened bond yields offset stimulus headlines
Wall Street futures were in the red ahead of the bell on Monday despite the US Senate passing Joe Biden's $1. 9trn Covid relief bill.
AstraZeneca vaccine reportedly effective against Brazilian Covid-19 strain
The Covid-19 vaccine developed by AstraZeneca and the University of Oxford does protect against the new strain of the virus detected in the South American, the results of a study conducted by Oxford researchers showed.
Circle Property upbeat on trading, regional office trends
Regional office investor Circle Property reported an improvement in rent collection for the December quarter on Monday, to 92%, with collections in the current quarter at 84%.
Trustpilot plots $1.4bn valuation ahead of London debut
Trustpilot has received commitments from a number of funds to act as cornerstone investors in its upcoming $1. 4bn flotation, the online reviews platform said on Monday.
London midday: Stocks in the black as Pearson rallies after results
London stocks were still in the black by midday on Monday, with Pearson pacing the advance after well-received results.
Amryt Pharma signs another distribution deal with Medison
Commercial-stage biopharmaceutical company Amryt Pharma announced the signing of a distribution agreement with Medison Pharma to distribute ‘Myalepta’ in Canada on Monday.